Nanosponges As A Revolutionary Drug Delivery System For Skin Disorders: Advancements, Challenges, And Future Perspectives
DOI:
https://doi.org/10.52783/jns.v14.3508Keywords:
Nanosponges, Targeted drug delivery, Skin disorders, Bioavailability enhancement, Dermatological nanomedicine, Controlled drug releaseAbstract
Nanotechnology has significantly transformed drug delivery, particularly in dermatology, where conventional treatments often face limitations such as poor bioavailability, systemic side effects, and inconsistent drug release. Nanosponges (NS), with their porous, sponge-like structure, have emerged as a promising solution for targeted and controlled drug delivery in treating various skin disorders, including psoriasis, acne, eczema, and skin cancer. These nanoscale carriers enhance drug solubility, stability, and bioavailability while reducing toxicity and side effects. This review explores the recent advancements in nanosponge-based formulations, including β-cyclodextrin, ethyl cellulose, and polymeric nanosponges, and their potential applications in dermatology. Various preparation techniques, such as solvent-based synthesis, emulsion-solvent diffusion, and ultrasound-assisted synthesis, are discussed in detail. Characterization techniques include particle size analysis, zeta potential, drug loading capacity, and release kinetics.
Despite their advantages, challenges such as large-scale manufacturing, regulatory concerns, and long-term biocompatibility must be addressed before clinical translation. Future research should optimise formulation stability, enhance specificity, and conduct rigorous in vivo studies to validate nanosponge efficacy. Integrating nanosponge technology with stimuli-responsive and intelligent delivery systems offers exciting prospects for personalized dermatological treatments.
This paper comprehensively reviews nanosponge-based drug delivery systems for dermatological applications, emphasizing their potential to revolutionize topical and transdermal therapy. Addressing existing challenges will be crucial for their successful clinical implementation, ultimately improving patient outcomes and treatment efficacy in dermatology.
Downloads
Metrics
References
Trotta F, Cavalli R. Characterization and applications of nanosponges. Nanomedicine (Lond). 2012;7(5):755-71.
Swaminathan S, Pastero L, Serpe L, et al. Cyclodextrin-based nanosponges encapsulating camptothecin: physicochemical characterization, stability and cytotoxicity. Eur J Pharm Biopharm. 2010;74(2):193-201.
Ansari KA, Torne SJ, Vavia PR, et al. Enhanced oral bioavailability of griseofulvin using nanosponges. Drug Dev Ind Pharm. 2011;37(5):581-90.
Kumar S, Jha AK. Nanosponges as versatile drug delivery system: an overview. Asian J Pharm Sci. 2021;16(1):19-34.
Challa R, Ahuja A, Ali J, et al. Cyclodextrins in drug delivery: an updated review. AAPS PharmSciTech. 2005;6(2): E329-57.
Patel E, Oswal R, Patel R. Nanosponges: A novel approach for drug delivery. Int J Pharm Sci Nanotechnol. 2012;5(2):1597-1606.
Sharma R, Pathak K. Nanosponges: emerging drug delivery system. Acta Pharm. 2012;62(1):23-34.
Lopedota AA, Denora N, Iacobellis NS, et al. Cyclodextrin-based nanosponges for topical delivery of poorly soluble drugs. Int J Pharm. 2021; 606:120879.
Shende PK, Gaud RS, Bakal RL, et al. Formulation and evaluation of a nanosponge-based delivery system for controlled release of telmisartan. Colloids Surf B Biointerfaces. 2013; 101:50-5.
Vavia PR, Londhe V, Bhaskar V. Cyclodextrin-based nanosponges: a promising approach for controlled drug delivery. Crit Rev Ther Drug Carrier Syst. 2011;28(4):257-92.
Kumar P, Singh S, Sinha V. Nanosponges: an emerging technology for targeted drug delivery. J Drug Deliv Sci Technol. 2020; 55:101480.
Kumar R, Singh AP, Senapati S, et al. Novel drug delivery applications of nanosponges in cancer therapy. J Control Release. 2017; 268:147-63.
Pandey S, Dash S, Choudhury H, et al. Application of cyclodextrin-based nanosponges in pharmaceuticals and life sciences. Biomed Pharmacother. 2021; 142:111987.
Mognetti B, Barberis A, Marino S, et al. In vitro enhancement of clotrimazole antifungal activity by inclusion in nano-cyclodextrins. Int J Pharm. 2020; 577:119043.
Pradhan S, Singh S, Dash S. Beta-cyclodextrin-based nanosponges as drug carriers in antimicrobial therapy. Pharm Dev Technol. 2019;24(1):55-63.
Choudhury H, Gorain B, Pandey M, et al. Development of topical nanoformulations for anti-inflammatory therapeutics. J Control Release. 2019; 308:25-41.
Jilsha G, Haritha NV, Kumar S, et al. Encapsulation efficiency of antifungal drugs in nanosponges: a comparative study. Drug Dev Ind Pharm. 2020;46(8):1312-23.
Uekama K, Hirayama F, Irie T. Cyclodextrin drug carrier systems. Chem Rev. 1998;98(5):2045-76.
Musumeci T, Ventura CA, Giannone I, et al. PLA/PLGA nanoparticles for sustained release of docetaxel. Int J Pharm. 2006;325(1-2):172-9.
Nehme H, Saadeh H, Baaboura S, et al. Cyclodextrin-based nanosponges for dermal delivery of azelaic acid. Pharmaceutics. 2021;13(3):431.
Mohammadi G, Nokhodchi A, Barzegar-Jalali M, et al. Physicochemical and antifungal evaluation of miconazole-loaded nanosponges. Drug Dev Ind Pharm. 2016;42(7):1053-64.
Cavalli R, Trotta F, Tumiatti V. Cyclodextrin-based nanosponges as drug carriers. Beilstein J Org Chem. 2006;2(1):3.
Jadhav KR, Gambhir MN, Kadam VJ. Development of nanosponge-loaded topical gel of fluconazole. Indian J Pharm Sci. 2018;80(4):735-42.
Kumari R, Garg T, Rath G, et al. Nanosponges: a promising nanocarrier system for drug delivery. Drug Deliv. 2016;23(2):459-72.
Montoto SS, Muraca G, Ruiz ME. Solid lipid nanoparticles for enhanced transdermal delivery of non-steroidal anti-inflammatory drugs. Eur J Pharm Sci. 2019; 128:112-21.
Yadav GV, Panchory HP. Nanosponges: a boon to the targeted drug delivery system. J Drug Deliv Ther. 2013;3(4):151-5.
Kataria SA, Middha AK, Sandhu P, et al. Formulation and characterization of ethylcellulose nanosponges for sustained release of ketoprofen. Int J Pharm Investing. 2018;8(2):71-8.
Singh R, Rath G, Goyal AK. Nanosponges: an emerging drug delivery approach. J Pharm Educ Res. 2013;4(2):9-17.
Tanwar YS, Naruka PS. Formulation and evaluation of nanosponge-based topical drug delivery system for controlled release of econazole nitrate. Indian J Pharm Educ Res. 2018;52(4):622-9.
Prajapati ST, Patel CG, Patel CN. Formulation and characterization of ethyl cellulose nanosponges for sustained release of ketoprofen. J Pharm Investing. 2020;50(3):251-64.
Bolorunduro O, Mohammed AS, Majekodunmi SO. Controlled drug release from beta-cyclodextrin nanosponges. Curr Drug Deliv. 2018;15(3):482-92.
Pawar A, Raics Z, Liederer BM, et al. Drug delivery applications of cyclodextrins: an updated review. Pharmaceutics. 2021;13(5):650.
Wang R, Yuan Z, Li J, et al. Nanosponges for topical drug delivery: current status and future perspectives. Drug Deliv Transl Res. 2020;10(6):1351-67.
Patel A, Dangi M, Mehta R. Development of nanosponge-loaded gels for controlled drug release in skin infections. J Pharm Res. 2017;11(1):17-22.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
